US HHS Secretary Becerra Says March-In Rights Not “Off the Table”
October 10, 2022
While pharma and biotech companies are still reeling from the passage of drug pricing reform in the US, their worries are still not over. Secretary Xavier Becerra of the Department of Health and Human Services (HHS) has mentioned that march-in rights are not “off the table.” The federal government has the power to take a drug’s patent and give it to other drugmakers in order to reduce the price for patients and payers, particularly those on the federal and state levels.
According to Peter Sullivan, “The idea has gained ground in the Democratic Party. Multiple 2020 presidential candidates touted the idea, though it tended to be progressives like Sens. Bernie Sanders (I-Vt.) and Elizabeth Warren (D-Mass.) more than Joe Biden.”
To read more, click here.
(Source: Axios, October 7th, 2022)
